AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.

AdAlta Ltd. ( ($AU:1AD) ) just unveiled an announcement. AdAlta Limited is set to host an investor webinar to discuss its ‘East to West’ cellular ...

Learn more about whether InterDigital, Inc. or Informatica Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed ...

LifeVantage Corporation ( NASDAQ: LFVN) Q2 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Reed Anderson – Managing Director-ICR Steve Fife – President and Chief Executive Officer Carl Aure ...

Cancer prevention relies on making intentional, consistent lifestyle changes, such as a plant-based diet, regular exercise, ...

FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors ...

Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

We go hands on with satellite provider Skylo, which also tells us about its strategy to power satellite-to-phone services ...

AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular ...